Torrent Pharmaceuticals Limited (TORNTPHARM) Q2 FY27 Financial Results: PAT ₹566 Cr & Revenue ₹4,921 Cr (2 announcements)

Torrent Pharmaceuticals reported record Q1 FY27 revenue of ₹4,921 crores, up 55% YoY, driven by organic growth and the JB Pharma acquisition, with operating EBITDA rising 61% to ₹1,664 crores and margins holding at 33.8%. Net profit reached ₹566 crores (11.5% margin), supported by 19% growth in India Rx and 27% growth in Brazil and CDMO segments. The company posted ₹21 crores in exceptional items during the quarter, reflecting integration impacts. Revenue growth in core segments remained robust at 17% YoY, with EBITDA margin stable at 33.3% for base business.

Torrent Pharmaceuticals announced that the audio recording of its conference call discussing financial results for the quarter ended June 30, 2026, is now available on its investor website at the provided URL, as disclosed in a regulatory filing to BSE and NSE under SEBI Listing Obligations and Disclosure Requirements.